[Treatment of chronic cardiac failure in 1997: obvious facts and uncertainties].
Komajda
M
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004039:Diet, Sodium-Restricted; D004077:Digoxin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D004232:Diuretics; D004077:Digoxin
Traitement de l'insuffisance cardiaque chronique en 1997: évidences et incertitudes.